mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |